Fact CheckerSign in

NCT04890314Completed

Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment

Source: ClinicalTrials.gov · Last updated 22 May 2025

Brief summary (registry, in English)

This study will use a population-based cohort design to study men with newly diagnosed low- and intermediate-risk prostate cancer at high-volume centers in Southern California (SCa) and New York State (NYS). Complications of contemporary treatments for prostate cancer and quality of life outcomes, such as general health, urinary, sexual, and bowel function, cancer anxiety, and treatment regret will be compared and tracked over the course of this study.

Status (registry)
Completed
Study type
Observational
Enrollment
1953 (actual)
First submitted
13 May 2021
Start date
15 May 2021
Primary completion date
30 Apr 2024
Lead sponsor
Weill Medical College of Cornell University
NCT number
NCT04890314

What you commit to

  • Study type: Observational
  • Participants enrolled: 1953
  • From 15 May 2021 to the primary completion date, 30 Apr 2024
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Clinically metastatic disease or high-risk PCa (T3a-T4, Gleason Grade Group 4 or 5 or PSA \>20 ng/mL

Other

  • Unable to read/speak English or Spanish
  • Unwilling or unable to give informed consent.

Who the study is looking for

  • Pathologically-confirmed clinically localized prostate adenocarcinoma with National Comprehensive Cancer Network (NCCN) low (T1-T2a, Gleason 6, Grade Group 1, PSA \<10 ng/mL) or intermediate risk (T2b-T2c or, Gleason 7, Grade Group 2 or 3 or PSA 10-20 ng/mL)72 at one of the selected hospitals in SCa and NYS
  • Diagnosis date during the 18 month recruitment window
  • Able to read/speak English or Spanish
  • Agree to participate by completing the baseline questionnaire

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
New York State Department of Health
Coordinator of this site? Confirm its status
AlbanyUnited StatesUnknown status
University of Kansas
Coordinator of this site? Confirm its status
Kansas CityUnited StatesUnknown status
University of Southern California
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Weill Cornell Medicine
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.